Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 

 

Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Dec 8, 2021

Dr. Jennifer Jones-McMeans is the Divisional Vice President of Global Clinical Affairs at Abbott's Vascular Business. She talks about recently released data from their Beyond Intervention Survey of 1800 stakeholders including 1289 vascular disease patients, 408 healthcare physicians, and 173 healthcare leaders from across 13 countries. The study looked particularly at Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD) which revealed these diseases disproportionately affect Black, Latino, and Native Americans.

Jennifer reports, "I think what Beyond Intervention allowed us to do is to see what the patient is feeling, experiencing, and how does that differ from what your healthcare provider or your healthcare leader is saying? Because one of the key findings that we found was that patient experience is maybe not as good as the healthcare provider may be thinking it is."

"And we know that when you look at these social determinants, and they can be anything from socioeconomic status, availability to care, education, impact of income, they all collide. And many times in certain areas, they can collide with race and ethnicity. So when you put people in an environment that is not supportive of health and that you're just reaching so many of the things that I spoke of before, you put them at risk for development of diseases, such as PAD and CAD."

@AbbottCardio #ClinicalTrials #VascularDisease #PAD #PeripheralArteryDisease #CAD #CoronaryArteryDisease #SDOH #SocialDeterminantsofHealth

Abbott.com

Listen to the podcast here

Abbott